As of 2025-06-21, the EV/EBITDA ratio of New Horizon Health Ltd (6606.HK) is -69.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 6606.HK's latest enterprise value is 5,240.18 mil HKD. 6606.HK's TTM EBITDA according to its financial statements is -75.39 mil HKD. Dividing these 2 quantities gives us the above 6606.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 25.1x | 24.2x |
| Forward P/E multiples | 8.4x - 9.4x | 9.2x |
| Fair Price | (1.87) - 0.74 | (0.61) |
| Upside | -113.2% - -94.8% | -104.3% |
| Date | EV/EBITDA |
| 2025-06-19 | -591.06 |
| 2025-06-18 | -591.06 |
| 2025-06-17 | -591.06 |
| 2025-06-16 | -591.06 |
| 2025-06-13 | -591.06 |
| 2025-06-12 | -591.06 |
| 2025-06-11 | -591.06 |
| 2025-06-10 | -591.06 |
| 2025-06-09 | -591.06 |
| 2025-06-06 | -591.06 |
| 2025-06-05 | -591.06 |
| 2025-06-04 | -591.06 |
| 2025-06-03 | -591.06 |
| 2025-06-02 | -591.06 |
| 2025-05-30 | -591.06 |
| 2025-05-29 | -591.06 |
| 2025-05-28 | -591.06 |
| 2025-05-27 | -591.06 |
| 2025-05-26 | -591.06 |
| 2025-05-23 | -591.06 |
| 2025-05-22 | -591.06 |
| 2025-05-21 | -591.06 |
| 2025-05-20 | -591.06 |
| 2025-05-19 | -591.06 |
| 2025-05-16 | -591.06 |
| 2025-05-15 | -591.06 |
| 2025-05-14 | -591.06 |
| 2025-05-13 | -591.06 |
| 2025-05-12 | -591.06 |
| 2025-05-09 | -591.06 |
| 2025-05-08 | -591.06 |
| 2025-05-07 | -591.06 |
| 2025-05-06 | -591.06 |
| 2025-05-02 | -591.06 |
| 2025-04-30 | -591.06 |
| 2025-04-29 | -591.06 |
| 2025-04-28 | -591.06 |
| 2025-04-25 | -591.06 |
| 2025-04-24 | -591.06 |
| 2025-04-23 | -591.06 |
| 2025-04-22 | -591.06 |
| 2025-04-17 | -591.06 |
| 2025-04-16 | -591.06 |
| 2025-04-15 | -591.06 |
| 2025-04-14 | -591.06 |
| 2025-04-11 | -591.06 |
| 2025-04-10 | -591.06 |
| 2025-04-09 | -591.06 |
| 2025-04-08 | -591.06 |
| 2025-04-07 | -591.06 |